Sarepta Therapeutics, Inc. (SRPT)

NASDAQ: SRPT · IEX Real-Time Price · USD

127.39

+3.14 (2.53%)

At close: Apr 25, 2024, 4:00 PM

124.26

-3.13 (-2.46%)

After-hours: Apr 25, 2024, 7:51 PM EDT

Sarepta Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1996
Revenue	1,243	933.01	701.89	540.1	380.83	301.03	154.58	5.42	1.25	9.76	Upgrade
Revenue Growth (YoY)	33.26%	32.93%	29.96%	41.82%	26.51%	94.74%	2751.58%	332.64%	-87.16%	-31.38%	Upgrade
Cost of Revenue	150.34	139.99	97.05	63.38	56.59	34.19	7.35	0.1	0	0	Upgrade
Gross Profit	1,093	793.02	604.84	476.72	324.25	266.84	147.23	5.32	1.25	9.76	Upgrade
Selling, General & Admin	481.87	451.42	282.66	317.88	284.81	207.76	122.68	83.75	75.04	49.32	Upgrade
Research & Development	877.39	877.09	771.18	722.34	560.91	401.84	166.71	188.27	146.39	94.23	Upgrade
Other Operating Expenses	1.56	0.71	10.71	0.66	184.09	0.87	29.48	0.03	0	0	Upgrade
Operating Expenses	1,361	1,329	1,065	1,041	1,030	610.47	318.87	272.05	221.44	143.55	Upgrade
Operating Income	-267.82	-536.2	-459.71	-564.16	-705.56	-343.63	-171.64	-266.73	-220.18	-133.79	Upgrade
Interest Expense / Income	0	0	0	0	0	0	0	0.54	-0.15	-0.78	Upgrade
Other Expense / Income	252.27	153.76	-40.76	-11.1	8.32	18.98	-123.01	-	-	2.78	Upgrade
Pretax Income	-520.1	-689.96	-418.95	-553.07	-713.88	-362.61	-48.63	-267.27	-220.03	-135.79	Upgrade
Income Tax	15.88	13.53	-0.17	1.06	1.2	-0.69	2.06	0	0	0	Upgrade
Net Income	-535.98	-703.49	-418.78	-554.13	-715.08	-361.92	-50.69	-267.27	-220.03	-135.79	Upgrade
Shares Outstanding (Basic)	92	88	81	78	74	66	59	49	42	40	Upgrade
Shares Outstanding (Diluted)	92	88	81	78	74	66	59	49	42	40	Upgrade
Shares Change	5.53%	7.75%	4.24%	5.90%	11.12%	12.64%	20.78%	15.15%	5.66%	18.25%	Upgrade
EPS (Basic)	-5.80	-8.03	-5.15	-7.11	-9.71	-5.46	-0.86	-5.49	-5.20	-3.39	Upgrade
EPS (Diluted)	-5.80	-8.03	-5.15	-7.11	-9.71	-5.46	-0.86	-5.49	-5.20	-3.39	Upgrade
Free Cash Flow	-577.1	-356.17	-481.66	25.26	-516.09	-449.82	-244	-251.16	-152.87	-153.98	Upgrade
Free Cash Flow Per Share	-6.25	-4.07	-5.93	0.32	-7.01	-6.79	-4.15	-5.16	-3.62	-3.85	Upgrade
Gross Margin	87.91%	85.00%	86.17%	88.26%	85.14%	88.64%	95.24%	98.14%	100.00%	100.00%	Upgrade
Operating Margin	-21.54%	-57.47%	-65.50%	-104.46%	-185.27%	-114.15%	-111.03%	-4920.31%	-17572.55%	-1371.21%	Upgrade
Profit Margin	-43.11%	-75.40%	-59.66%	-102.60%	-187.77%	-120.22%	-32.79%	-4930.18%	-17560.26%	-1391.71%	Upgrade
Free Cash Flow Margin	-46.42%	-38.17%	-68.62%	4.68%	-135.52%	-149.42%	-157.84%	-4633.11%	-12200.00%	-1578.18%	Upgrade
EBITDA	-461.21	-635.36	-369.61	-513.33	-683.33	-350.37	-40.54	-261.12	-214.94	-132.88	Upgrade
EBITDA Margin	-37.09%	-68.10%	-52.66%	-95.04%	-179.43%	-116.39%	-26.22%	-4816.81%	-17153.79%	-1361.87%	Upgrade
Depreciation & Amortization	58.89	54.6	49.34	39.74	30.55	12.25	8.09	5.61	5.25	3.69	Upgrade
EBIT	-520.1	-689.96	-418.95	-553.07	-713.88	-362.61	-48.63	-266.73	-220.18	-136.57	Upgrade
EBIT Margin	-41.83%	-73.95%	-59.69%	-102.40%	-187.45%	-120.45%	-31.46%	-4920.31%	-17572.55%	-1399.69%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).